Lykke Eriksen Peter, Sørensen Michael, Grønbæk Henning, Hamilton-Dutoit Stephen, Vilstrup Hendrik, Thomsen Karen Louise
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens boulevard 99, Aarhus, Denmark.
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens boulevard 99, Aarhus, Denmark.
Clin Res Hepatol Gastroenterol. 2019 Oct;43(5):551-560. doi: 10.1016/j.clinre.2019.01.001. Epub 2019 Feb 13.
Non-alcoholic fatty liver disease (NAFLD) is a major health concern affecting 25% of the world's population. It is generally held that a fatty liver does not influence liver function, but quantitative measurements of metabolic liver functions have not been systematically performed. We aimed to study selected hepatocellular metabolic functions in patients with different stages of NAFLD.
Twenty-five non-diabetic, biopsy-proven NAFLD patients [12 with simple steatosis; 13 with non-alcoholic steatohepatitis (NASH)] and ten healthy controls were included in a cross-sectional study. Hepatocyte cytosolic function was assessed by the galactose elimination capacity (GEC), mitochondrial-cytosolic metabolic capacity by the functional hepatic nitrogen clearance (FHNC), microsomal function by the aminopyrine breath test, and excretory liver function by indocyanine green (ICG) elimination.
GEC was 20% higher in NAFLD than in controls [3.15 mmol/min (2.9-3.41) vs. 2.62 (2.32-2.93); P = 0.02]. FHNC was 30% lower in NAFLD [23.3 L/h (18.7-28.9) vs. 33.1 (28.9-37.9); P = 0.04], more so in simple steatosis [19.1 L/h (13.9-26.2); P = 0.003] and non-significantly in NASH [27.9 L/h (20.6-37.8); P = 0.19]. Aminopyrine metabolism was 25% lower in simple steatosis [8.9% (7.0-10.7)] and 50% lower in NASH [6.0% (4.5-7.5)] than in controls [11.9% (9.3-12.8)] (P < 0.001). ICG elimination was intact.
The hepatocellular metabolic functions were altered in a manner that was dissociated both by different effects on different liver functions and by different effects of different stages of NAFLD. Thus, NAFLD has widespread consequences for metabolic liver function, even in simple steatosis.
非酒精性脂肪性肝病(NAFLD)是一个重大的健康问题,影响着全球25%的人口。一般认为脂肪肝不影响肝功能,但尚未系统地对肝脏代谢功能进行定量测量。我们旨在研究不同阶段NAFLD患者的特定肝细胞代谢功能。
一项横断面研究纳入了25例经活检证实的非糖尿病NAFLD患者[12例为单纯性脂肪肝;13例为非酒精性脂肪性肝炎(NASH)]和10名健康对照者。通过半乳糖清除能力(GEC)评估肝细胞胞质功能,通过功能性肝氮清除率(FHNC)评估线粒体-胞质代谢能力,通过氨基比林呼气试验评估微粒体功能,通过吲哚菁绿(ICG)清除评估肝脏排泄功能。
NAFLD患者的GEC比对照组高20%[3.15 mmol/min(2.9 - 3.41)vs. 2.62(2.32 - 2.93);P = 0.02]。NAFLD患者的FHNC低30%[23.3 L/h(18.7 - 28.9)vs. 33.1(28.9 - 37.9);P = 0.04],在单纯性脂肪肝中更低[19.1 L/h(13.9 - 26.2);P = 0.003],在NASH中无显著差异[27.9 L/h(20.6 - 37.8);P = 0.19]。单纯性脂肪肝患者的氨基比林代谢比对照组低25%[8.9%(7.0 - 10.7)],NASH患者低50%[6.0%(4.5 - 7.5)],而对照组为[11.9%(9.3 - 12.8)](P < 0.001)。ICG清除功能正常。
肝细胞代谢功能以一种方式发生改变,这种改变既体现在对不同肝功能的不同影响上,也体现在NAFLD不同阶段的不同影响上。因此,即使在单纯性脂肪肝阶段,NAFLD对肝脏代谢功能也有广泛影响。